Last edition
News about "viral vector manufacturing"
Merck Acquires Mirus Bio to Advance Viral Vector Bioprocessing
Merck has completed the acquisition of Mirus Bio for approximately USD 600 million (around EUR 550 million), following regulatory clearances and the fulfillment of other customary closing conditions.
Viral Vector Manufacturing | 03/08/2024 | By Aishwarya | 192
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members